{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:34:36Z","timestamp":1789169676079,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s12033-024-01320-5","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T03:02:44Z","timestamp":1731466964000},"page":"4167-4177","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Astragaloside IV Inhibits Lung Injury and Fibrosis Induced by PM2.5 by Targeting RUNX1 Through miR-362-3p"],"prefix":"10.1007","volume":"67","author":[{"given":"Hao","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GenTan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JunJing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2718-626X","authenticated-orcid":false,"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,13]]},"reference":[{"key":"1320_CR1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.mam.2018.08.004","volume":"65","author":"D Chanda","year":"2019","unstructured":"Chanda, D., Otoupalova, E., Smith, S. R., Volckaert, T., De Langhe, S. P., & Thannickal, V. J. (2019). Developmental pathways in the pathogenesis of lung fibrosis. Molecular Aspects of Medicine, 65, 56\u201369.","journal-title":"Molecular Aspects of Medicine"},{"key":"1320_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118308","volume":"260","author":"S Vishnupriya","year":"2020","unstructured":"Vishnupriya, S., Priya Dharshini, L. C., Sakthivel, K. M., & Rasmi, R. R. (2020). Autophagy markers as mediators of lung injury-implication for therapeutic intervention. Life Sciences, 260, 118308.","journal-title":"Life Sciences"},{"key":"1320_CR3","doi-asserted-by":"publisher","first-page":"113356","DOI":"10.1016\/j.ecoenv.2022.113356","volume":"234","author":"H Li","year":"2022","unstructured":"Li, H., Zhao, Z., Luo, X. S., Fang, G., Zhang, D., Pang, Y., Huang, W., Mehmood, T., & Tang, M. (2022). Insight into urban PM(2.5) chemical composition and environmentally persistent free radicals attributed human lung epithelial cytotoxicity. Ecotoxicology and Environmental Safety, 234, 113356.","journal-title":"Ecotoxicology and Environmental Safety"},{"issue":"11","key":"1320_CR4","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.3390\/ijerph16112017","volume":"16","author":"Y Huang","year":"2019","unstructured":"Huang, Y., Bao, M., Xiao, J., Qiu, Z., & Wu, K. (2019). Effects of PM(2.5) on cardio-pulmonary function injury in open manganese mine workers. International Journal of Environmental Research and Public Health, 16(11), 2017.","journal-title":"International Journal of Environmental Research and Public Health"},{"key":"1320_CR5","doi-asserted-by":"publisher","first-page":"120017","DOI":"10.1016\/j.envpol.2022.120017","volume":"313","author":"C Zhao","year":"2022","unstructured":"Zhao, C., Pu, W., Wazir, J., Jin, X., Wei, L., Song, S., Su, Z., Li, J., Deng, Y., & Wang, H. (2022). Long-term exposure to PM2.5 aggravates pulmonary fibrosis and acute lung injury by disrupting Nrf2-mediated antioxidant function. Environmental Pollution, 313, 120017.","journal-title":"Environmental Pollution"},{"key":"1320_CR6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/bs.apha.2019.08.002","volume":"87","author":"J Zhang","year":"2020","unstructured":"Zhang, J., Wu, C., Gao, L., Du, G., & Qin, X. (2020). Astragaloside IV derived from Astragalus membranaceus: A research review on the pharmacological effects. Advances in Pharmacology, 87, 89\u2013112.","journal-title":"Advances in Pharmacology"},{"issue":"1","key":"1320_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/fcp.12232","volume":"31","author":"L Li","year":"2017","unstructured":"Li, L., Hou, X., Xu, R., Liu, C., & Tu, M. (2017). Research review on the pharmacological effects of astragaloside IV. Fundamental & Clinical Pharmacology, 31(1), 17\u201336.","journal-title":"Fundamental & Clinical Pharmacology"},{"key":"1320_CR8","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.2147\/DDDT.S416091","volume":"17","author":"J Tan","year":"2023","unstructured":"Tan, J., Yi, J., Cao, X., Wang, F., Xie, S., & Dai, A. (2023). Untapping the potential of Astragaloside IV in the battle against respiratory diseases. Drug Design, Development and Therapy, 17, 1963\u20131978.","journal-title":"Drug Design, Development and Therapy"},{"key":"1320_CR9","doi-asserted-by":"publisher","first-page":"109186","DOI":"10.1016\/j.intimp.2022.109186","volume":"112","author":"X Wang","year":"2022","unstructured":"Wang, X., Wang, Y., Huang, D., Shi, S., Pei, C., Wu, Y., Shen, Z., Wang, F., & Wang, Z. (2022). Astragaloside IV regulates the ferroptosis signaling pathway via the Nrf2\/SLC7A11\/GPX4 axis to inhibit PM2.5-mediated lung injury in mice. International Immunopharmacology, 112, 109186.","journal-title":"International Immunopharmacology"},{"key":"1320_CR10","doi-asserted-by":"publisher","first-page":"107290","DOI":"10.1016\/j.intimp.2020.107290","volume":"91","author":"Y Wu","year":"2021","unstructured":"Wu, Y., Xiao, W., Pei, C., Wang, M., Wang, X., Huang, D., Wang, F., & Wang, Z. (2021). Astragaloside IV alleviates PM2.5-induced lung injury in rats by modulating TLR4\/MyD88\/NF-kappaB signalling pathway. International Immunopharmacology, 91, 107290.","journal-title":"International Immunopharmacology"},{"key":"1320_CR11","doi-asserted-by":"publisher","first-page":"153912","DOI":"10.1016\/j.phymed.2021.153912","volume":"96","author":"Z Wang","year":"2022","unstructured":"Wang, Z., Wu, Y., Pei, C., Wang, M., Wang, X., Shi, S., Huang, D., Wang, Y., Li, S., Xiao, W., He, Y., & Wan, F. (2022). Astragaloside IV pre-treatment attenuates PM2.5-induced lung injury in rats: Impact on autophagy, apoptosis and inflammation. Phytomedicine, 96, 153912.","journal-title":"Phytomedicine"},{"issue":"1","key":"1320_CR12","doi-asserted-by":"publisher","first-page":"7747","DOI":"10.1080\/21655979.2021.1982845","volume":"12","author":"H Li","year":"2021","unstructured":"Li, H., Yao, C., Shi, K., Zhao, Y., Du, J., Hu, D., & Liu, Z. (2021). Astragaloside IV attenuates hypoxia\/reoxygenation injury-induced apoptosis of type II alveolar epithelial cells through miR-21-5p. Bioengineered, 12(1), 7747\u20137754.","journal-title":"Bioengineered"},{"issue":"6","key":"1320_CR13","doi-asserted-by":"publisher","first-page":"4199","DOI":"10.1007\/s11033-020-05543-y","volume":"47","author":"P Xie","year":"2020","unstructured":"Xie, P., Deng, M., Sun, Q., Jiang, B., Xu, H., Liu, J., Zhou, Y., Ma, Y., & Chen, Z. (2020). Curcumin protects BV2 cells against lipopolysaccharide-induced injury via adjusting the miR-362-3p\/TLR4 axis. Molecular Biology Reports, 47(6), 4199\u20134208.","journal-title":"Molecular Biology Reports"},{"issue":"6","key":"1320_CR14","doi-asserted-by":"publisher","first-page":"220","DOI":"10.14715\/cmb\/2021.67.6.29","volume":"67","author":"G Liu","year":"2022","unstructured":"Liu, G., Tian, R., Mao, H., & Ren, Y. (2022). Effect of lncRNA SNHG15 on LPS-induced vascular endothelial cell apoptosis, inflammatory factor expression and oxidative stress by targeting miR-362-3p. Cellular and Molecular Biology (Noisy-le-grand), 67(6), 220\u2013227.","journal-title":"Cellular and Molecular Biology (Noisy-le-grand)"},{"issue":"4","key":"1320_CR15","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s11064-020-03224-7","volume":"46","author":"J Zhou","year":"2021","unstructured":"Zhou, J., Li, Z., Zhao, Q., Wu, T., Zhao, Q., & Cao, Y. (2021). Knockdown of SNHG1 alleviates autophagy and apoptosis by regulating miR-362-3p\/Jak2\/stat3 pathway in LPS-injured PC12 cells. Neurochemical Research, 46(4), 945\u2013956.","journal-title":"Neurochemical Research"},{"issue":"5","key":"1320_CR16","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s12012-020-09631-0","volume":"21","author":"M Shi","year":"2021","unstructured":"Shi, M., Ma, X., Yang, Q., Wang, W., Li, X., Song, X., Li, Y., Xie, Y., & Dang, Y. (2021). miR-362-3p targets Orosomucoid 1 to promote cell proliferation, restrain cell apoptosis and thereby mitigate hypoxia\/reoxygenation-induced cardiomyocytes injury. Cardiovascular Toxicology, 21(5), 387\u2013398.","journal-title":"Cardiovascular Toxicology"},{"key":"1320_CR17","doi-asserted-by":"publisher","first-page":"103659","DOI":"10.1016\/j.etap.2021.103659","volume":"86","author":"N Zhang","year":"2021","unstructured":"Zhang, N., Li, P., Lin, H., Shuo, T., Ping, F., Su, L., & Chen, G. (2021). IL-10 ameliorates PM2.5-induced lung injury by activating the AMPK\/SIRT1\/PGC-1alpha pathway. Environmental Toxicology and Pharmacology, 86, 103659.","journal-title":"Environmental Toxicology and Pharmacology"},{"issue":"5","key":"1320_CR18","first-page":"7506","volume":"15","author":"R Li","year":"2018","unstructured":"Li, R., Zhou, R., & Zhang, J. (2018). Function of PM2.5 in the pathogenesis of lung cancer and chronic airway inflammatory diseases. Oncology Letters, 15(5), 7506\u20137514.","journal-title":"Oncology Letters"},{"issue":"12","key":"1320_CR19","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.2174\/1389450116666150907104742","volume":"17","author":"M Shahzad","year":"2016","unstructured":"Shahzad, M., Shabbir, A., Wojcikowski, K., Wohlmuth, H., & Gobe, G. C. (2016). The antioxidant effects of Radix Astragali (Astragalus membranaceus and related species) in protecting tissues from injury and disease. Current Drug Targets, 17(12), 1331\u20131340.","journal-title":"Current Drug Targets"},{"issue":"36","key":"1320_CR20","doi-asserted-by":"publisher","first-page":"e30478","DOI":"10.1097\/MD.0000000000030478","volume":"101","author":"XM Pang","year":"2022","unstructured":"Pang, X. M., Cai, H. H., Zhao, J., Sun, P. Y., Shi, J. J., Zhang, Y. L., Liu, J., Liu, Z. C., & Zheng, X. (2022). Efficacy of astragalus in the treatment of radiation-induced lung injury based on traditional Chinese medicine: A systematic review and meta-analysis of 25 RCTs. Medicine (Baltimore), 101(36), e30478.","journal-title":"Medicine (Baltimore)"},{"key":"1320_CR21","doi-asserted-by":"publisher","first-page":"3017571","DOI":"10.1155\/2018\/3017571","volume":"2017","author":"L Qin","year":"2018","unstructured":"Qin, L., Tan, H. L., Wang, Y. G., Xu, C. Y., Feng, J., Li, M., & Dou, Y.-Q. (2018). Astragalus membranaceus and Salvia miltiorrhiza Ameliorate lipopolysaccharide-induced acute lung injury in rats by regulating the toll-like receptor 4\/nuclear factor-kappa B signaling pathway. Evidence-Based Complementary and Alternative Medicine, 2017, 3017571.","journal-title":"Evidence-Based Complementary and Alternative Medicine"},{"key":"1320_CR22","doi-asserted-by":"publisher","first-page":"4707","DOI":"10.2147\/JIR.S312167","volume":"14","author":"C Pei","year":"2021","unstructured":"Pei, C., Wang, F., Huang, D., Shi, S., Wang, X., Wang, Y., Li, S., Wu, Y., & Wang, Z. (2021). Astragaloside IV protects from PM2.5-induced lung injury by regulating autophagy via inhibition of PI3K\/Akt\/mTOR signaling in vivo and in vitro. Journal of Inflammation Research, 14, 4707\u20134721.","journal-title":"Journal of Inflammation Research"},{"issue":"9","key":"1320_CR23","doi-asserted-by":"publisher","first-page":"4354","DOI":"10.1111\/jcmm.13725","volume":"22","author":"W Qian","year":"2018","unstructured":"Qian, W., Cai, X., Qian, Q., Zhang, W., & Wang, D. (2018). Astragaloside IV modulates TGF-beta1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis. Journal of Cellular and Molecular Medicine, 22(9), 4354\u20134365.","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"2","key":"1320_CR24","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3892\/ijmm.2020.4813","volume":"47","author":"H Jin","year":"2021","unstructured":"Jin, H., Jiao, Y., Guo, L., Ma, Y., Zhao, R., Li, X., Shen, L., Zhou, Z., Kim, S. C., & Liu, J. (2021). Astragaloside IV blocks monocrotaline-induced pulmonary arterial hypertension by improving inflammation and pulmonary artery remodeling. International Journal of Molecular Medicine, 47(2), 595\u2013606.","journal-title":"International Journal of Molecular Medicine"},{"issue":"1\u20132","key":"1320_CR25","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1159\/000502865","volume":"105","author":"B Liu","year":"2020","unstructured":"Liu, B., Zhao, H., Wang, Y., Zhang, H., & Ma, Y. (2020). Astragaloside IV attenuates lipopolysaccharides-induced pulmonary epithelial cell injury through inhibiting autophagy. Pharmacology, 105(1\u20132), 90\u2013101.","journal-title":"Pharmacology"},{"issue":"2","key":"1320_CR26","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1536\/ihj.22-232","volume":"64","author":"J Wang","year":"2023","unstructured":"Wang, J., Wang, X., Cao, M., Zhang, L., & Lin, J. (2023). CircUSP39\/miR-362-3p\/TRAF3 axis mediates hypoxia\/reoxygenation-induced cardiomyocyte oxidative stress, inflammation, and apoptosis. International Heart Journal, 64(2), 263\u2013273.","journal-title":"International Heart Journal"},{"issue":"1","key":"1320_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.31083\/j.jin.2019.01.12","volume":"18","author":"Y Hu","year":"2019","unstructured":"Hu, Y., Liu, Q., Zhang, M., Yan, Y., Yu, H., & Ge, L. (2019). MicroRNA-362-3p attenuates motor deficit following spinal cord injury via targeting paired box gene 2. Journal of Integrative Neuroscience, 18(1), 57\u201364.","journal-title":"Journal of Integrative Neuroscience"},{"issue":"2","key":"1320_CR28","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1165\/rcmb.2016-0319OC","volume":"57","author":"X Tang","year":"2017","unstructured":"Tang, X., Sun, L., Jin, X., Chen, Y., Zhu, H., Liang, Y., Wu, Q., Han, X., Liang, J., Liu, X., Liang, Z., Wang, G., & Luo, F. (2017). Runt-related transcription factor 1 regulates LPS-induced acute lung injury via NF-kappaB signaling. American Journal of Respiratory Cell and Molecular Biology, 57(2), 174\u2013183.","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"1320_CR29","doi-asserted-by":"publisher","first-page":"110318","DOI":"10.1016\/j.intimp.2023.110318","volume":"120","author":"C Xiao","year":"2023","unstructured":"Xiao, C., Li, Q., Xiao, J., Chen, X., Yuan, J., Li, S., Li, W., Gao, D., Li, L., & Shen, F. (2023). miR-9 targeting RUNX1 improves LPS-induced alveolar hypercoagulation and fibrinolysis inhibition through NF-kappaB inactivation in ARDS. International Immunopharmacology, 120, 110318.","journal-title":"International Immunopharmacology"},{"issue":"4","key":"1320_CR30","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1002\/jcp.30684","volume":"237","author":"S Dubey","year":"2022","unstructured":"Dubey, S., Dubey, P. K., Umeshappa, C. S., Ghebre, Y. T., & Krishnamurthy, P. (2022). Inhibition of RUNX1 blocks the differentiation of lung fibroblasts to myofibroblasts. Journal of Cellular Physiology, 237(4), 2169\u20132182.","journal-title":"Journal of Cellular Physiology"},{"issue":"8","key":"1320_CR31","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41419-020-02889-w","volume":"11","author":"S Lin","year":"2020","unstructured":"Lin, S., Zhang, R., Xu, L., Ma, R., Xu, L., Zhu, L., Hu, J., & An, X. (2020). LncRNA Hoxaas3 promotes lung fibroblast activation and fibrosis by targeting miR-450b-5p to regulate Runx1. Cell Death & Disease, 11(8), 706.","journal-title":"Cell Death & Disease"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-024-01320-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-024-01320-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-024-01320-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T04:17:59Z","timestamp":1761711479000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-024-01320-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,13]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["1320"],"URL":"https:\/\/doi.org\/10.1007\/s12033-024-01320-5","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,13]]},"assertion":[{"value":"22 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animal experiments were complied with the ARRIVE guidelines and performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. The experiments were approved by the Institutional Animal Care and Use Committee of Yantai Qishan Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}